Health Technology/clinical-trials

Tele-Group CBT Family Intervention Trial Opens for Schizophrenia Dyads — Can Digital Delivery Reduce Expressed Emotion and Caregiver Burden?

247 Health News Editorial

·

25 July 2026

·

4 min read

·clinical-trials

A new randomised controlled trial from The Hong Kong Polytechnic University is testing a tele-group Cognitive Behavioural Family Intervention (tgCBFI) for dyads of people with schizophrenia and their family caregivers, targeting expressed emotion — one of the strongest modifiable predictors of psychiatric relapse. With 200 participants and a mixed-method design, the trial could provide pivotal evidence for scalable, digitally delivered family psychoeducation in Chinese-speaking communities worldwide.

Originally reported by ClinicalTrials.gov

References

  1. 1.The Hong Kong Polytechnic University. (2025). Effectiveness of a tele-group cognitive behavioural family intervention (tgCBFI) for people with schizophrenia and their families: A mixed-method study (NCT07121166). ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07121166
  2. 2.Butzlaff, R. L., & Hooley, J. M. (1998). Expressed emotion and psychiatric relapse: A meta-analysis. Archives of General Psychiatry, 55(6), 547–552. https://doi.org/10.1001/archpsyc.55.6.547
  3. 3.Pharoah, F., Mari, J. J., Rathbone, J., & Wong, W. (2010). Family intervention for schizophrenia. Cochrane Database of Systematic Reviews, (12), CD000088. https://doi.org/10.1002/14651858.CD000088.pub3
  4. 4.Creswell, J. W., & Plano Clark, V. L. (2017). Designing and conducting mixed methods research (3rd ed.). SAGE Publications.
  5. 5.Cole, J. D., & Leavey, G. (1995). The assessment of expressed emotion: A review of measurement issues and clinical utility. Clinical Psychology Review, 15(4), 291–306. https://doi.org/10.1016/0272-7358(95)00013-7
  6. 6.GBD 2019 Mental Disorders Collaborators. (2022). Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet Psychiatry, 9(2), 137–150. https://doi.org/10.1016/S2215-0366(21)00395-3
Share:XLinkedIn
2

247 Health News Editorial

247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service